Little is known about predictors of body image


Little is known about predictors of body image.

Methods: The present study investigated

how much body image in women with BC is determined by individual factors (surgery type, medical treatments, disease stage, women’s age, depressive symptoms) and by dyadic variables (relationship satisfaction and duration, dyadic coping). Furthermore, two different aspects of women’s body image were assessed: self acceptance and perceptions of partners’ acceptance. Ninety-eight German women with early stage BC and their partners participated.

Results: Individual and dyadic aspects of body image were differentially related to body image. Women’s depressive symptoms and men’s marital satisfaction predicted women’s self-acceptance, but not women’s perceptions of their partners’ acceptance of their appearance. Female’s relationship satisfaction and perspective on common dyadic coping predicted women’s perceptions of their partner’s acceptance of their appearance.

Conclusions: The findings suggest interventions that include strategies to reduce women’s depressive symptoms

and build relationship satisfaction, might reduce body image difficulties in women after BC. Copyright (C) 2009 John Wiley & Sons, Ltd.”
“Background: The purpose of this multicenter Spanish study was to evaluate the response to immediate-release methylphenidate by children and adults diagnosed with attention-deficit/hyperactivity Vactosertib disorder (ADHD), as well as to obtain information on current therapy patterns and safety characteristics.

Methods: This selleck products multicenter, observational, retrospective, noninterventional study included 730 patients aged 4-65 years with a diagnosis of ADHD. Information was obtained based on a review of medical records for the years 2002-2006 in sequential order.

Results: The ADHD predominantly inattentive subtype affected 29.7% of

patients, ADHD predominantly hyperactive-impulsive was found in 5.2%, and the combined subtype in 65.1%. Overall, a significant lower Clinical Global Impression (CGI) score and mean number of DSM-IV TR (Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision) symptoms by subtype were found after one year of treatment with immediate-release methylphenidate; CGI decreased from 4.51 to 1.69, symptoms of inattention from 7.90 to 4.34, symptoms of hyperactivity from 6.73 to 3.39, and combined subtype symptoms from 14.62 to 7.7. Satisfaction with immediate-release methylphenidate after one year was evaluated as “”very satisfied”" or “”satisfied”" by 86.90% of the sample; 25.75% of all patients reported at least one adverse effect. At the end of the study, 41.47% of all the patients treated with immediate-release methylphenidate were still receiving it, with a mean time of 3.80 years on therapy.

Comments are closed.